Buchumschlag

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs

Aim: To determine the main ultrastructural changes in MCF-7 sublines sensitive and resistant to cytotoxic action of anticancer drugs, resulting from the treatment with conventional and liposomal forms of cisplatin and doxorubicin. Methods: Electron microscopy, light microscopy, MTT-test. Results: It...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2010
Hauptverfasser:	Yurchenko, O.V., Rusetskaya, N.V., Naleskina, L.A., Chekhun, V.F.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2010
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/138593
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs / O.V. Yurchenko, N.V. Rusetskaya, L.A. Naleskina, V.F. Chekhun // Experimental Oncology. — 2010. — Т. 32, № 1. — С. 24-28. — Бібліогр.: 27 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2011)

Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
von: Rusetskaya, N.V., et al.
Veröffentlicht: (2009)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
von: Chekhun, V.F., et al.
Veröffentlicht: (2014)

Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
von: Zhaleiko, I.O., et al.
Veröffentlicht: (2014)

Green tea, red wine and lemon extracts reduce experimental tumor growth and cancer drug toxicity
von: Zaletok, S., et al.
Veröffentlicht: (2015)

Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer
von: Paliychuk, O.V., et al.
Veröffentlicht: (2018)

Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability
von: Krasnopolsky, Y.M., et al.
Veröffentlicht: (2017)

In vitro modification of cisplatin cytotoxicity with magnetic fluid
von: Chekhun, V.F., et al.
Veröffentlicht: (2013)

The anticancer efficiency of the xenogeneic vaccine and the indication for its use
von: Symchych, T.V., et al.
Veröffentlicht: (2014)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
von: Symchych, T.V., et al.
Veröffentlicht: (2015)

Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing ehrlich solid carcinoma
von: Symchych, T.V., et al.
Veröffentlicht: (2017)

Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
von: Boroday, N.V., et al.
Veröffentlicht: (2018)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)

Expression of cancer-associated genes in prostate tumors
von: Rosenberg, E.E., et al.
Veröffentlicht: (2017)

Recurrence of borderline ovarian tumors
von: Svintsitskiy, V.S., et al.
Veröffentlicht: (2013)

Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards CIS-DDP resistance
von: Pyaskovskaya, O.N., et al.
Veröffentlicht: (2007)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
von: Bubnovskaya, L., et al.
Veröffentlicht: (2012)

Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
von: Todor, I.N., et al.
Veröffentlicht: (2015)

Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL)
von: Shman, T.V., et al.
Veröffentlicht: (2011)

Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
von: Solopan, S., et al.
Veröffentlicht: (2011)

In VIVO anti-tumor activities of gelatin
von: Inamura, Y., et al.
Veröffentlicht: (2009)

Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells
von: Pushkarev, V.M., et al.
Veröffentlicht: (2009)

Effects of Paclitaxel and combination of the drug with radiation therapy in an in vivo model of anaplastic thyroid carcinoma
von: Pushkarev, V.M., et al.
Veröffentlicht: (2011)

DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay
von: Buchynska, L.G., et al.
Veröffentlicht: (2017)

Cannabinoid receptors expression in bone marrow trephine biopsy of chronic lymphocytic leukaemia patients treated with purine analogues
von: Piszcz, J.A., et al.
Veröffentlicht: (2007)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
von: Melnikov, A.A., et al.
Veröffentlicht: (2012)

EPR spectroscopy studies of changes in erythrocyte membranes in patients with laryngeal cancer
von: Burlaka, Y.B., et al.
Veröffentlicht: (2017)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
von: Zykova, M.G., et al.
Veröffentlicht: (2012)

Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer
von: Skachkova, O.V., et al.
Veröffentlicht: (2013)

Expression OF p53, p21WAF1/CIP1 , p16INK4A and Ki-67 proteins in serous ovarian tumors
von: Buchynska, L.G., et al.
Veröffentlicht: (2007)

Aspisol inhibits tumor growth and induces apoptosis in breast cancer
von: Zhu, X.G., et al.
Veröffentlicht: (2008)

Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
von: Lukyanova, N.Yu., et al.
Veröffentlicht: (2009)

Experimental validation of prevention of the development of stochastic effects of low doses of ionizing radiation based on the analysis of human lymphocytes’ chromosome aberrations
von: Domina, E.A., et al.
Veröffentlicht: (2013)

Efficacy of natural L-asparagine in the complex therapy for malignant tumors in experimental studies
von: Urazova, L.N., et al.
Veröffentlicht: (2011)